The relation between mobile phone use and brain tumor was investigated in a population-based case-control study in Japan. The study is part of the INTERPHONE project.
Regular mobile phone use was defined as use at least once a week for 6 months one year before diagnosis. Exposure was assessed by following the protocol of the INTERPHONE study using a questionnaire. Furthermore, a new approach was used for estimating the specific absorption rate (SAR) inside the tumor based on a head model taking account of spatial relationships between tumor localisation and intracranial radiofrequency distribution (Nagaoka et al, 2004). Three SAR-derived exposure indices (mean maximal SAR, cumulative maximal SAR-year, and cumulative maximal SAR-hour) were calculated and categorized in four quartiles.
Group | Description |
---|---|
Reference group 1 | mobile phone use: non-user |
Group 2 | mobile phone use: regular user |
Reference group 3 | cumulative length of use in years: non-user |
Group 4 | cumulative length of use in years: lowest |
Group 5 | cumulative length of use in years: mid-low |
Group 6 | cumulative length of use in years: mid-high |
Group 7 | cumulative length of use in years: highest |
Reference group 8 | cumulative call time in hours: non-user |
Group 9 | cumulative call time in hours: lowest |
Group 10 | cumulative call time in hours: mid-low |
Group 11 | cumulative call time in hours: mid-high |
Group 12 | cumulative call time in hours: highest |
Reference group 13 | type of mobile phone used: non-user |
Group 14 | type of mobile phone used: analog and digital |
Group 15 | type of mobile phone used: digital |
Reference group 16 | tumor laterality and side of mobile phone use: no or contralateral use |
Group 17 | tumor laterality and side of mobile phone use: ipsilateral |
Reference group 18 | tumor laterality and side of mobile phone use: no or ipsilateral use |
Group 19 | tumor laterality and side of mobile phone use: contralateral |
Reference group 20 | mean maximal SAR: non-exposed |
Group 21 | mean maximal SAR: lowest |
Group 22 | mean maximal SAR: mid-low |
Group 23 | mean maximal SAR: mid-high |
Group 24 | mean maximal SAR: highest |
Reference group 25 | mean maximal SAR: non-exposed |
Group 26 | mean maximal SAR: < 0.001 W/kg |
Group 27 | mean maximal SAR: 0.001 - 0.01 W/kg |
Group 28 | mean maximal SAR: ≥ 0.01 W/kg |
Reference group 29 | cumulative maximal SAR-year: non-exposed |
Group 30 | cumulative maximal SAR-year: lowest |
Group 31 | cumulative maximal SAR-year: mid-low |
Group 32 | cumulative maximal SAR-year: mid-high |
Group 33 | cumulative maximal SAR-year: highest |
Reference group 34 | cumulative maximal SAR-year: non-exposed |
Group 35 | cumulative maximal SAR-year: < 0.001 W/kg |
Group 36 | cumulative maximal SAR-year: 0.001 - 0.01 W/kg |
Group 37 | cumulative maximal SAR-year: 0.01 - 0.1 W/kg |
Group 38 | cumulative maximal SAR-year: ≥ 0.1 W/kg |
Reference group 39 | cumulative maximal SAR-hour: non-exposed |
Group 40 | cumulative maximal SAR-hour: lowest |
Group 41 | cumulative maximal SAR-hour: mid-low |
Group 42 | cumulative maximal SAR-hour: mid-high |
Group 43 | cumulative maximal SAR-hour: highest |
Reference group 44 | cumulative maximal SAR-hour: non-exposed |
Group 45 | cumulative maximal SAR-hour: < 0.1 W/kg |
Group 46 | cumulative maximal SAR-hour: 0.1 - 1 W/kg |
Group 47 | cumulative maximal SAR-hour: 1 - 10 W/kg |
Group 48 | cumulative maximal SAR-hour: ≥ 10 W/kg |
Cases | Controls | |
---|---|---|
Eligible | 455 | 1,122 |
Participants | 322 | 683 |
glioma: 88 cases; meningioma: 132 cases; pituitary adenoma: 102 cases
No consistent increase was observed in the overall risk of glioma, meningioma and pituitary adenoma among mobile phone users. No increasing trend in risk in relation to cumulative length of use or cumulative call time was foung. The results of the SAR-derived exposure indices also showed no substantial increased risk for glioma or meningioma.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.